The Simulations Driving the World's Response to COVID-19
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
COVID-19: How Hateful Extremists Are Exploiting the Pandemic
COVID-19 How hateful extremists are exploiting the pandemic July 2020 Contents 3 Introduction 5 Summary 6 Findings and recommendations 7 Beliefs and attitudes 12 Behaviours and activities 14 Harms 16 Conclusion and recommendations Commission for Countering Extremism Introduction that COVID-19 is punishment on China for their treatment of Uighurs Muslims.3 Other conspiracy theories suggest the virus is part of a Jewish plot4 or that 5G is to blame.5 The latter has led to attacks on 5G masts and telecoms engineers.6 We are seeing many of these same narratives reoccur across a wide range of different ideologies. Fake news about minority communities has circulated on social media in an attempt to whip up hatred. These include false claims that mosques have remained open during 7 Since the outbreak of the coronavirus (COVID-19) lockdown. Evidence has also shown that pandemic, the Commission for Countering ‘Far Right politicians and news agencies [...] Extremism has heard increasing reports of capitalis[ed] on the virus to push forward their 8 extremists exploiting the crisis to sow division anti-immigrant and populist message’. Content and undermine the social fabric of our country. such as this normalises Far Right attitudes and helps to reinforce intolerant and hateful views We have heard reports of British Far Right towards ethnic, racial or religious communities. activists and Neo-Nazi groups promoting anti-minority narratives by encouraging users Practitioners have told us how some Islamist to deliberately infect groups, including Jewish activists may be exploiting legitimate concerns communities1 and of Islamists propagating regarding securitisation to deliberately drive a anti-democratic and anti-Western narratives, wedge between communities and the British 9 claiming that COVID-19 is divine punishment state. -
14 Novembre 2018 La Recherche Sur La Technologie "Gene Drive" Peut
14 Novembre 2018 La recherche sur la technologie "gene drive" peut bénéficier la conservation et la santé publique La communauté internationale est confrontée à des défis existentiels qui compromettent notre future, de la perte catastrophique de la biodiversité à de graves menaces pour la santé publique. Les cas de paludisme sont à nouveau à la hausse après des décennies de progrès, et les écosystèmes fragiles connaissent une intensification croissante des extinctions. Ces défis nécessitent des outils nouveaux et complémentaires si nous voulons atteindre les Objectifs de Développement Durable et les Objectifs d'Aichi.i. Alors que la Convention sur la Diversité Biologique (CDB) se réunit pour la 14ème Conférence des Parties (COP14) en Égypte en novembre, les autorités des pays du monde entier auront l'occasion de réaffirmer l'importance de permettre la recherche pour soutenir l'innovation responsable et la prise de décision basée sur des évidences. Fermer la porte à la recherche en créant des barrières arbitraires, une forte incertitude, et des retards indéterminés limitera considérablement notre capacité à fournir des réponses aux questions que les responsables politiques, les régulateurs, et le public sont en train de poser. Le moratoire proposé au sein du CDB sur les lâchers expérimentaux empêcherait l’évaluation complète des utilisations potentielles du « gene drive ». La faisabilité et les modalités de tout lâcher expérimental devrait plutôt être évaluées au cas par cas. Une grande partie des progrès que nous avons réalisés au cours du siècle dernier en matière d’amélioration des moyens de subsistance et du bien-être des communautés du monde entier est le résultat de l’accroissement des connaissances acquises grâce à la recherche scientifique. -
Social Media, Misinformation and the Covid-19 Pandemic
SOCIAL MEDIA, MISINFORMATION AND HOW CAN PEOPLE IDENTIFY ONLINE MISINFORMATION THE COVID-19 PANDEMIC RELATED TO COVID-19? Developed with assistance from David Hill, MD > Online misinformation is common, but during the COVID-19 pandemic it has become “viral.” It is important to check the source for any information you read online. > A good rule of thumb: if you are looking for scientific information, it is best to access it from scientific or federal websites (Centers for Disease Control, US Food and Drug Administration, National Institutes of Health, US Health and Human Services) or from state and local health departments because they vet the information and provide reliable sources. HOW CAN PEOPLE POINT OUT MISINFORMATION IN A CONSTRUCTIVE MANNER? > Avoid telling someone to take a post down. This can create “forbidden fruit” and actually encourage others to share it. If you are going to point out misinformation, it is best to also provide links to credible sources with accurate information. HOW CAN SOCIAL MEDIA BE HELPFUL TO THE GENERAL PUBLIC DURING THE COVID-19 PANDEMIC? > Social media is a great way to share resources and confirm information. > It allows us to socialize when we may be stuck at home due to social-distancing measures. > It also provides a way to check in with your friends and family to see how they are managing during the pandemic. HOW CAN SOCIAL MEDIA BE HELPFUL TO HEALTH CARE PROFESSIONALS DURING THE PANDEMIC? > Social media helps health care professionals to stay up-to-date with rapidly evolving information. They can see information when it is released, as well as expert reactions to it. -
SOCIAL DISTANCING + COVID-19: Staying Home During a Pandemic Saves Lives
SOCIAL DISTANCING + COVID-19: Staying home during a pandemic saves lives It is important that people understand the seriousness of this situation. In just a week’s time, Louisiana went from zero positive cases of COVID-19 to more than 100 cases. This is one of the highest per capita rates of COVID-19 cases in the entire country, and it is expected to continue unless we each change our behaviors. Right now, everyone is urged to take aggressive measures to contain this virus. We all have a role to play in protecting not just ourselves but our neighbors, friends and everyone else we interact with. What is social distancing and how does it work? When we look at what has worked in stopping the spread of COVID-19 in other countries, it’s protective measures to encourage “social distance.” o Social distancing is a public health practice that aims to prevent sick people from coming into close contact with healthy people in order to reduce opportunities for disease transmission. o Social distancing can include large-scale measures like closing schools and bars, as well as individual decisions such as avoiding crowds and minimizing non- essential travel. With COVID-19, the goal of social distancing is to slow down the outbreak to reduce the chance of infection among high-risk populations and to reduce the burden on health care systems and workers. Experts call this “flattening the curve” – successful social distancing can prevent surges in illness that could overwhelm health care systems. Social distancing can help lower the pace and extent of spread of COVID-19. -
Effects of Social Distancing on the Spreading of COVID-19
www.nature.com/scientificreports OPEN Efects of social distancing on the spreading of COVID‑19 inferred from mobile phone data Hamid Khataee1, Istvan Scheuring2,3, Andras Czirok4,5 & Zoltan Neufeld1* A better understanding of how the COVID‑19 pandemic responds to social distancing eforts is required for the control of future outbreaks and to calibrate partial lock‑downs. We present quantitative relationships between key parameters characterizing the COVID‑19 epidemiology and social distancing eforts of nine selected European countries. Epidemiological parameters were extracted from the number of daily deaths data, while mitigation eforts are estimated from mobile phone tracking data. The decrease of the basic reproductive number ( R0 ) as well as the duration of the initial exponential expansion phase of the epidemic strongly correlates with the magnitude of mobility reduction. Utilizing these relationships we decipher the relative impact of the timing and the extent of social distancing on the total death burden of the pandemic. Te COVID-19 pandemic started in late 2019 and within a few months it spread around the World infecting 9 million people, out of which half a million succumbed to the disease. As of June 2020, the transmission of the disease is still progressing in many countries, especially in the American continent. While there have been big regional diferences in the extent of the pandemic, in most countries of Europe and Asia the initial exponen- tial growth has gradually transitioned into a decaying phase 8. An epidemic outbreak can recede either due to reduction of the transmission probability across contacts, or due to a gradual build up of immunity within the population. -
SARS-Cov-2 Variants ACKNOWLEDGEMENTS
SARS-CoV-2 variants ACKNOWLEDGEMENTS This report was developed by PHG Foundation for FIND (the Foundation for Innovative New Diagnostics). The work was supported by Unitaid and UK aid from the British people. We would like to thank all those who contributed to the development and review of this report. Lead writers Chantal Babb de Villiers (PHG Foundation) Laura Blackburn (PHG Foundation) Sarah Cook (PHG Foundation) Joanna Janus (PHG Foundation) Reviewers Devy Emperador (FIND) Jilian Sacks (FIND) Marva Seifert (FIND/UCSD) Anita Suresh (FIND) Swapna Uplekar (FIND) Publication date: 11 March 2021 URLs correct as of 4 March 2021 SARS-CoV-2 variants CONTENTS 1 Introduction ............................................................................................................................ 3 2 SARS-CoV-2 variants and mutations .................................................................................... 3 2.1 Definitions of variants of concern ...................................................................................... 4 2.2 Initial variants of concern identified ................................................................................... 5 2.3 Variants of interest ............................................................................................................ 7 3 Impact of variants on diagnostics ........................................................................................ 7 3.1 Impact of variants of concern on diagnostics ................................................................... -
MRC Centre for Outbreak Analysis and Modelling
Centre for Outbreak Analysis and Modelling MRC Centre for ANNUAL REPORT Outbreak Analysis and Modelling www.imperial.ac.uk/medicine/outbreaks 2012 The Centre specialises in quantitative epidemiology encompassing mathematical modelling, statistical analysis and evolutionary epidemiology, to aid the control and Director’s message treatment of infectious diseases. April 2013 sees the Centre renewed for a second 5-year Consortium (led by Tim Hallett) and the Vaccine Modelling term, after we received an unprecedented 10 out of 10 Initiative – are up for renewal. However, grants are only score from the MRC subcommittee, which assessed the one aspect of the relationship. As important are the close performance of the Centre over its first term. Just as the working relationships between staff in the Centre and the work of the Centre over that time has been very much a Foundation, which sees our research increasingly used to team effort, so was the success of the renewal. inform Foundation strategy and delivery. The last few months have seen us start to drive through Despite its title, the Centre’s mission rapidly evolved to our strategy for the next 5 years. A crucial aspect of this encompass delivering innovative epidemiological analysis is to boost capacity in key research areas. It is therefore not only of novel infectious disease outbreaks, but also of my pleasure to welcome new academic staff into the endemic diseases of major global health significance. Our Centre. Xavier Didelot joined us last year as a lecturer in work on polio, malaria and HIV reflects this. However, the pathogen genetics, and our expertise in evolutionary and last few months have highlighted the ongoing relevance of genetic research will be further boosted this year by the our original mission to enhance preparedness and response recruitment of at least one additional member of academic to emerging disease threats. -
Interim Pre-Pandemic Planning Guidance: Community
Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States— Early, Targeted, Layered Use of Nonpharmaceutical Interventions NT O E F D M E T F R E A N P S E E D U N A I IC TE R D S ME TATES OF A OF TRAN NT SP E O M R T T R A A T P I O E N D U N A I C T I E R D E M ST A ATES OF Page 2 was blank in the printed version and has been omitted for web purposes. Page 2 was blank in the printed version and has been omitted for web purposes. Interim Pre-Pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States— Early, Targeted, Layered Use of Nonpharmaceutical Interventions February 2007 Page 4 was blank in the printed version and has been omitted for web purposes. Page 4 was blank in the printed version and has been omitted for web purposes. Contents I Executive Summary ........................................................................ 07 II Introduction .................................................................................. 17 III Rationale for Proposed Nonpharmaceutical Interventions .......................... 23 IV Pre-pandemic Planning: the Pandemic Severity Index ............................. 31 V Use of Nonpharmaceutical Interventions by Severity Category ................... 35 VI Triggers for Initiating Use of Nonpharmaceutical Interventions ................... 41 VII Duration of Implementation of Nonpharmaceutical Interventions.......................... 45 VIII Critical Issues for the Use of Nonpharmaceutical Interventions ................... 47 IX Assessment of the Public on Feasibility of Implementation and Adherence ..... 49 X Planning to Minimize Consequences of Community Mitigation Strategy ....... 51 XI Testing and Exercising Community Mitigation Interventions .................... -
The Social Impacts of COVID-19 Reset Not Restart: Taking Advantage of a Crisis for Social Change
The social impacts of COVID-19 Reset not restart: taking advantage of a crisis for social change August 2020 Preface In the short term, responding to In Australia, the focus has appropriately been We need to understand, monitor and document COVID-19 has required governments to on the public health response and cushioning these affects – positive and negative – to ensure prioritise managing the health crisis and the economic impact. The decisions associated our immediate and long-term policy responses responding to the economic fallout. with the economic and health impacts have account of these changes, take advantage of flow-on effects to our society. To date we have the positive aspects, and provide an effective observed negative changes in our broader social mechanism to address the social impacts Societies have grappled with different approaches, indicators, including rates of domestic and family of COVID-19. with varying degrees of success. Though success violence, mental health, child protection, and does not just sit in the hands of government justice system. – the actions of communities, our culture and businesses shape the nation’s trajectory. While Yet it is not all bad news. We have witnessed some nations have adopted effective tracing using social connectedness on a global scale, and surveillance techniques such as facial recognition innovation and adoption of new technologies or CCTV footage, this use of surveillance may be at an unprecedented rate. The use of new less welcome in other nations. Similarly, the social technologies is also changing the way we deliver fabric and understanding of one’s individual role in social services. -
Evaluating the Roadmap out of Lockdown: Step 3
2021-05-05 Imperial College London Evaluating the Roadmap out of Lockdown: Step 3 Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Edward S Knock, Pablo N Perez-Guzman, Tara Mangal, Alexandra B Hogan, Erik M Volz, Azra Ghani, Neil M Ferguson, Marc Baguelin, Anne Cori MRC Centre for Global Infectious Disease Analysis, Imperial College London 1. Summary In this report, we summarise the findings of our evaluation of the successive easing of non- pharmaceutical interventions (NPIs) as set out in the UK Government’s Roadmap out of Lockdown. Full methods, data used, and parameter values assumed for forward projections are given in the technical appendix. Key parameters relevant to interpretation of findings are provided in the text. Results and assumptions refer to England unless otherwise specified. 1. We estimate the current level of transmission, Reff, is approximately 1 in England. This estimate may not fully capture the impact of schools opening after Easter given the 3-week delay before changes in contact rates are reflected in surveillance data streams. 2. Based on PHE data available to 28 April 2021, 64% of the adult population in England have received at least one vaccine dose and 26% have received two doses. Under our central assumptions on vaccine effectiveness, this translates to 40% of adults (or 31% of the whole population) protected against symptomatic disease and 49% of adults (or 38% of the whole population) protected against severe disease (hospitalisation) via vaccination. Note this also includes individuals who are also protected due to recovery from past infection. 3. We estimate that an additional 15% of the population who are not protected through vaccination are currently protected due to recovery from past infection. -
Weekly COVID-19 Pandemic Briefing – Mathematical Modelling and Response Decisions
Transcript Webinar: Weekly COVID-19 Pandemic Briefing – Mathematical Modelling and Response Decisions Professor David Heymann CBE Distinguished Fellow, Global Health Programme, Chatham House, Executive Director, Communicable Diseases Cluster, World Health Organization (1998-2003) Professor Azra Ghani Chair of Infectious Disease Epidemiology, Imperial College London Chair: Emma Ross Senior Consulting Fellow, Global Health Programme, Chatham House Event date: 01 July 2020 The views expressed in this document are the sole responsibility of the speaker(s) and participants, and do not necessarily reflect the view of Chatham House, its staff, associates or Council. Chatham House is independent and owes no allegiance to any government or to any political body. It does not take institutional positions on policy issues. This document is issued on the understanding that if any extract is used, the author(s)/speaker(s) and Chatham House should be credited, preferably with the date of the publication or details of the event. Where this document refers to or reports statements made by speakers at an event, every effort has been made to provide a fair representation of their views and opinions. The published text of speeches and presentations may differ from delivery. © The Royal Institute of International Affairs, 2020. 10 St James’s Square, London SW1Y 4LE T +44 (0)20 7957 5700 F +44 (0)20 7957 5710 www.chathamhouse.org Patron: Her Majesty The Queen Chair: Jim O’Neill Director: Dr Robin Niblett Charity Registration Number: 208223 2 Webinar: Weekly COVID-19 Pandemic Briefing – Mathematical Modelling and Response Decisions Emma Ross Good morning and thank you for joining us for this week’s Chatham House COVID-19 briefing with Distinguished Fellow David Heymann. -
Planning for a Coronavirus Pandemic: a Guide
Public Health - Seattle & King County February 2020 PLANNING FOR A CORONAVIRUS PANDEMIC A guide for businesses and organizations If the novel coronavirus (COVID-19) continues to spread around the world, it could become a pandemic. Though global by definition, pandemics have local impacts. Pandemics can cause absenteeism, alter patterns of business and travel, interrupt supply chains, and affect the daily operations of your business. A pandemic isn't an isolated incident, but an event that unfolds over time, sometimes spanning many months. You can minimize the impact to your organization by creating a plan that clearly outlines roles, responsibilities, and policies. I N I T I A T E IDENTIFY PLAN A well-designed plan can protect your employees and keep your OBJECTIVES business functioning during a disease outbreak. Objectives might include: Reduce the spread of disease among staff. Protect people at higher risk for complications. Maintain business operations. Minimize impact on your customers and business partners. OUTLINE KEY Determine what people and resources are required for your business to operate. BUSINESS What jobs are needed to carry on day-to-day activities? FUNCTIONS Who are your key partners, suppliers, and contractors? What raw materials does your business need to function? Consider how your business will adjust if resources are constrained. How can you back fill positions if employees are absent? How can you accomplish critical tasks if key partners are unavailable? How can you adapt if your supply chain is interrupted? ASSESS Identify health risks your employees may face. In the course of their duties, are employees likely to: WORKPLACE Have face-to-face contact with large numbers of people? EXPOSURE RISK Spend time in work sites, like health care settings, where they may come into contact with ill people? Handle materials that could be contaminated, like laboratory samples or healthcare waste? Workers with increased risk include those involved in healthcare, deathcare, airline operations, waste management.